Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience

BackgroundIt is critically important to study the real-world data of FDA-approved medications to understand the response rates and toxicities observed in the real-world population not represented in the clinical trials.MethodsWe reviewed charts of patients diagnosed with metastatic, hormone receptor...

Full description

Bibliographic Details
Main Authors: Sabah Alaklabi, Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey O’Connor, Amy Early, Ellis G. Levine, Shipra Gandhi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
alpelisib
piqray
PIK3CA
breast cancer
real-world
effectiveness
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1012391/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1012391/full

Similar Items